This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novus Pharma LLC. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Massimo Broggini - Innovator in Oncogenetics
Introduction
Massimo Broggini is an influential inventor based in Bresso, Italy, known for his significant contributions to the field of oncology. His groundbreaking research focuses on the intricacies of gene regulation and the apoptotic process, which are vital for understanding cancer mechanisms and developing therapeutic strategies.
Latest Patents
Broggini holds a patent that encapsulates his innovative work on the "Oncosuppressive Gene." This patent involves the isolation and characterization of an oncosuppressive gene that plays a crucial role in the apoptotic process, which is regulated by the p53 and p73 polypeptides. Additionally, the patent outlines the sequences involved in gene regulation and the genetic constructs derived from this research.
Career Highlights
Broggini works at Novuspharma S.p.a., a company dedicated to advancing pharmaceutical development and research. His role at Novuspharma emphasizes his commitment to translating scientific discoveries into meaningful healthcare applications that can benefit patients worldwide.
Collaborations
Throughout his career, Massimo has collaborated with esteemed experts in the field, including Maurizio D'Incalci. This partnership highlights the importance of teamwork in scientific research, often leading to advancements that might not be possible in isolation.
Conclusion
Massimo Broggini's innovative spirit and dedication to oncology continue to inspire many in the scientific community. With his patented work and collaborative efforts, he remains a pivotal figure in the pursuit of effective cancer therapies, showcasing the vital connection between research and groundbreaking innovations.